Cargando…
The Impact of P-Glycoprotein on Opioid Analgesics: What’s the Real Meaning in Pain Management and Palliative Care?
Opioids are widely used in cancer and non-cancer pain management. However, many transporters at the blood–brain barrier (BBB), such as P-glycoprotein (P-gp, ABCB1/MDR1), may impair their delivery to the brain, thus leading to opioid tolerance. Nonetheless, opioids may regulate P-gp expression, thus...
Autores principales: | Coluzzi, Flaminia, Scerpa, Maria Sole, Rocco, Monica, Fornasari, Diego |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695906/ https://www.ncbi.nlm.nih.gov/pubmed/36430602 http://dx.doi.org/10.3390/ijms232214125 |
Ejemplares similares
-
Current and Future Therapeutic Options in Pain Management: Multi-mechanistic Opioids Involving Both MOR and NOP Receptor Activation
por: Coluzzi, Flaminia, et al.
Publicado: (2022) -
A Closer Look at Opioid-Induced Adrenal Insufficiency: A Narrative Review
por: Coluzzi, Flaminia, et al.
Publicado: (2023) -
Naldemedine: A New Option for OIBD
por: Coluzzi, Flaminia, et al.
Publicado: (2020) -
Pain Management in Childhood Leukemia: Diagnosis and Available Analgesic Treatments
por: Coluzzi, Flaminia, et al.
Publicado: (2020) -
New Perspectives on the Adverse Effects of NSAIDs in Cancer Pain: An Italian Delphi Study from the Rational Use of Analgesics (RUA) Group †
por: Varrassi, Giustino, et al.
Publicado: (2022)